1. Signaling Pathways
  2. NF-κB
  3. NF-κB

NF-κB (核因子κB)

Nuclear factor-κB; Nuclear factor-kappaB

NF-κB(活化 B 细胞的核因子 κ 轻链增强子)是一种控制 DNA 转录的蛋白质复合物。NF-κB 存在于几乎所有动物细胞类型中,并参与细胞对压力、细胞因子、自由基、紫外线照射、氧化 LDL 以及细菌或病毒抗原等刺激的反应。NF-κB 在调节对感染的免疫反应中起着关键作用。NF-κB 的错误调节与癌症、炎症和自身免疫性疾病、感染性休克、病毒感染和免疫发育不当有关。NF-κB 还与突触可塑性和记忆过程有关。哺乳动物 NF-κB 家族中有五种蛋白质:NF-κB1、NF-κB2、RelA、RelB、c-Rel。

NF-κB (Nuclear factor kappa-light-chain-enhancer of activated B cells) is a protein complex that controls transcription of DNA. NF-κB is found in almost all animal cell types and is involved in cellular responses to stimuli such as stress, cytokines, free radicals, ultraviolet irradiation, oxidized LDL, and bacterial or viral antigens. NF-κB plays a key role in regulating the immune response to infection. Incorrect regulation of NF-κB has been linked to cancer, inflammatory, and autoimmune diseases, septic shock, viral infection, and improper immune development. NF-κB has also been implicated in processes of synaptic plasticity and memory. There are five proteins in the mammalian NF-κB family: NF-κB1, NF-κB2, RelA, RelB, c-Rel.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-B0900
    Anethole

    茴香脑

    Inhibitor 99.78%
    Anethole 是一类具有口服活性的芳香族化合物,用作调味剂,广泛存在于自然界中。Anethole 具有抗癌、抗炎、抗氧化、抗菌、抗真菌、麻醉、雌激素、中枢神经系统抑制、催眠、杀虫剂、和胃保护作用。Anethole 可以用于氧化应激相关皮肤病、前列腺癌的研究 。
    Anethole
  • HY-N6246
    Asperulosidic Acid

    车叶草苷酸

    Inhibitor 99.72%
    Asperulosidic Acid (ASPA) 车叶草苷酸是一种具有生物活性的环烯醚萜苷,从白花蛇舌草 (Hedyotis diffusa Willd) 的草药中提取的。 Asperulosidic Acid (ASPA) 具有抗肿瘤,抗氧化和抗炎作用。 Asperulosidic Acid (ASPA) 通过抑制 NF-κB 和丝裂原活化蛋白激酶 (MAPK) 信号通路抑制炎性细胞因子(TNF-α,IL-6) 释放发挥抗炎作用。
    Asperulosidic Acid
  • HY-N0589
    Dehydrodiisoeugenol

    脱氢二异丁香酚

    Inhibitor 99.98%
    Dehydrodiisoeugenol 从 Myristica fragrans Houtt 中分离得到,具有抗炎和抗菌作用。Dehydrodiisoeugenol 抑制 LPS 刺激的小鼠巨噬细胞中 NF-κB 活化和环氧合酶 (COX)-2 基因的表达。
    Dehydrodiisoeugenol
  • HY-N2450
    Sulforaphene Inhibitor 99.80%
    Sulforaphene 可从萝卜籽中提取得到,对绒毛叶种子的ED50 值为2 x 10-4 M。Sulforaphene 促进癌细胞的凋亡,通过下调EGFRp-ERK1/2NF‐κB 等抑制癌细胞迁移。
    Sulforaphene
  • HY-N2056
    11-​Keto-​beta-​boswellic acid

    11-酮-β-乳香酸

    Inhibitor 99.96%
    11-Keto-beta-boswellic acid (11-Keto-β-boswellic acid) 是一种五环三萜酸,来自俗称印度乳香 (Indian Frankincense) 的乳香树 (Boswellia serrate) 树皮的油树脂。 11-Keto-beta-boswellic acid 具有抗炎活性,主要是由于抑制 5-脂氧合酶 (5-lipoxygenase; 5-LOX)白三烯 (leukotriene)NF-κB的激活和肿瘤坏死因子 α 的产生。
    11-​Keto-​beta-​boswellic acid
  • HY-116626
    SM-7368 Inhibitor 99.77%
    SM-7368 是一种 NF-kB 抑制剂,靶向抑制下游的 MAPK p38。SM-7368 还抑制 TNF-α 诱导的 MMP-9 上调。SM-7368 可用于靶向 TNF-α 介导的肿瘤侵袭和转移的化疗研究。
    SM-7368
  • HY-N3021
    D-chiro-Inositol

    D-手性肌醇

    Inhibitor ≥98.0%
    D-chiro-Inositol 是一种肌醇的差向异构体,具有改善糖代谢、抗肿瘤、抗炎和抗氧化的活性。D-chiro-Inositol 通过改善胆汁酸分泌和减轻氧化应激,有效缓解胆汁淤积。它通过模拟胰岛素的作用来改善胰岛素抵抗,降低高血糖和循环胰岛素水平,减少血清雄激素,并改善 X 综合征的一些代谢异常。此外,D-chiro-Inositol 可诱导促炎因子 (如 Nf-κB) 和细胞因子 (如 TNF-α) 的减少,从而发挥抗炎作用。D-chiro-Inositol 可用于肝硬化、乳腺癌、2 型糖尿病和多囊卵巢综合征的研究。
    D-chiro-Inositol
  • HY-N2055
    Kaempferol 3-O-sophoroside Inhibitor 99.84%
    Kaempferol 3-O-sophoroside 是一种具有口服活性的 Kaempferol 的衍生物。Kaempferol 3-O-sophoroside 具有抗炎、镇痛和抗抑郁的作用。Kaempferol 3-O-sophoroside 是 HMGB1 (High mobility group box 1) 的细胞表面受体 toll 样受体 (TLR) 2/4 的抑制剂 ,也可以通过阻止 NF-κB 的表达激活和 TNF-α 的产生而发挥抗炎作用。Kaempferol 3-O-sophoroside 通过结合 AMP 活化蛋白激酶 (AMPK) 促进脑源性神经营养因子 (BDNF) 的产生和自噬增强,发挥抗抑郁作用。 Kaempferol 3-O-sophoroside 有望用于炎症与神经疾病领域研究。
    Kaempferol 3-O-sophoroside
  • HY-N2086
    Ethyl palmitate

    棕榈酸乙酯

    Inhibitor 99.05%
    Ethyl palmitate (Ethyl hexadecanoate) 是一种 CHIKV 病毒抑制剂,EC50 值为 0.0068 μM。Ethyl palmitate 可以降低内毒素血症大鼠中的 TNF-αIL-6NF-κB 水平,具有抗炎活性。
    Ethyl palmitate
  • HY-156519
    ALPK1-IN-3 Inhibitor 99.19%
    ALPK1-IN-3 (T007) 是 ALPK1 的抑制剂。ALPK1-IN-3 在脓毒症急性肾损伤动物模型中抑制肾脏促炎基因表达,提高动物存活率。详细信息请参考专利文献WO2022063153A1 中的化合物 T007。ALPK1-IN-3 是一种点击化学试剂。它含有 Alkyne 基团,可以和含有 Azide 基团的分子发生铜催化的叠氮-炔环加成反应 (CuAAc)。
    ALPK1-IN-3
  • HY-N5048
    Galloylpaeoniflorin Inhibitor 98.04%
    Galloylpaeoniflorin 是 NF-κB 抑制剂。并且 Galloylpaeoniflorin 是一种DNA裂解的抑制剂。
    Galloylpaeoniflorin
  • HY-145532
    S-Allylmercaptocysteine Inhibitor
    S-allylmercaptocysteine 是一种从大蒜中提取的有机硫化合物,对各种肺部疾病具有抗炎和抗氧化作用。S-allylmercaptocysteine 通过多种途径发挥抗癌作用,如通过 TGF-β 信号通路诱导癌细胞凋亡 (apoptosis),或通过降低 NF-κb 活性和上调 Nrf2 来达到抗炎和抗氧化的作用。
    S-Allylmercaptocysteine
  • HY-N6029
    Dehydroevodiamine hydrochloride

    盐酸去氢吴茱萸碱

    99.93%
    Dehydroevodiamine hydrochloride 从吴茱萸叶中分离得到。
    Dehydroevodiamine hydrochloride
  • HY-N0041
    Ginsenoside Rb3

    人参皂苷 Rb3

    Inhibitor 99.12%
    Ginsenoside Rb3 是从 Panax ginseng C. A. Meyer 中提取的。在 293T 细胞系中 Ginsenoside Rb3 抑制 TNFα 诱导的 NF-κB 转录活性,IC50 为 8.2 μM。Ginsenoside Rb3 还抑制 COX-2iNOS mRNA的诱导。
    Ginsenoside Rb3
  • HY-101364
    CHPG Activator ≥99.0%
    CHPG 是一个选择性的 mGluR5 激动剂,并且通过 TSG-6/NF-κB 途径减弱 BV2 小神经胶质细胞 SO2 诱导的氧化应激和炎症。 CHPG 通过 ERKAkt 途径在体外和体内预防创伤性脑损伤 (TBI)。
    CHPG
  • HY-14806A
    Teneligliptin hydrobromide

    氢溴酸替格列汀

    Inhibitor 99.99%
    Teneligliptin (MP-513) hydrobromide 是一种口服活性的和选择性的 二肽基肽酶 4 (DPP-4) 抑制剂 (对人和大鼠酶的 IC50s 分别为 0.37 和 0.29 nM)。Teneligliptin hydrobromide 可改善血糖水平,可用于 2 型糖尿病相关的研究。
    Teneligliptin hydrobromide
  • HY-N0896
    Inulicin

    旋覆花次内酯

    Inhibitor 99.91%
    Inulicin (1-O-Acetylbritannilactone) 是一种活性化合物,抑制 VEGF 介导的 SrcFAK 活化。Inulicin (1-O-Acetylbritannilactone) 还抑制 LPS 诱导的 PGE2 产生和 COX-2 表达,以及抑制 NF-κB 活化和易位。
    Inulicin
  • HY-N0613
    Sauchinone

    三白草酮

    Inhibitor 99.88%
    Sauchinone 是一种非对映异构的木脂素,从 Saururus chinensis 中获得。Sauchinone 通过抑制 I-κBα 磷酸化和 p65 核易位来抑制 LPS 诱导的 iNOS,TNF-α 和 COX-2 表达。 Sauchinone 具有抗炎和抗氧化活性。
    Sauchinone
  • HY-147561
    ALPK1-IN-1 Inhibitor 99.14%
    ALPK1-IN-1 (Compound A001) 是一种有效的 α-激酶 1 (ALPK1) 抑制剂。ALPK1 是一种胞质内丝/苏氨酸蛋白激酶,通过与叉头相关结构域 (TIFA) 依赖的促炎 NF-κB 信号通路的 TRAF蛋白相互作用,在激活对细菌的先天免疫反应中起重要作用。
    ALPK1-IN-1
  • HY-N0803
    Myrcene

    月桂烯

    Inhibitor
    Myrcene (β-Myrcene) 是一种芳香族挥发性化合物,可抑制 TNFα 诱导的 NF-κB 的活性。Myrcene 具有抗侵袭作用,并阻滞细胞周期,诱导癌细胞凋亡 (apoptosis)。Myrcene 对脑缺血具有神经保护作用,还具有抗炎、抗氧化应激的活性。
    Myrcene
目录号 产品名 / 同用名 应用 反应物种

NF-κB transcription factors are critical regulators of immunity, stress responses, apoptosis and differentiation. In mammals, there are five members of the transcription factor NF-κB family: RELA (p65), RELB and c-REL, and the precursor proteins NF-κB1 (p105) and NF-κB2 (p100), which are processed into p50 and p52, respectively. NF-κB transcription factors bind as dimers to κB sites in promoters and enhancers of a variety of genes and induce or repress transcription. NF-κB activation occurs via two major signaling pathways: the canonical and the non-canonical NF-κB signaling pathways[1]

 

The canonical NF-κB pathway is triggered by signals from a large variety of immune receptors, such as TNFR, TLR, and IL-1R, which activate TAK1. TAK1 then activates IκB kinase (IKK) complex, composed of catalytic (IKKα and IKKβ) and regulatory (NEMO) subunits, via phosphorylation of IKKβ. Upon stimulation, the IKK complex, largely through IKKβ, phosphorylates members of the inhibitor of κB (IκB) family, such as IκBα and the IκB-like molecule p105, which sequester NF-κB members in the cytoplasm. IκBα associates with dimers of p50 and members of the REL family (RELA or c-REL), whereas p105 associates with p50 or REL (RELA or c-REL). Upon phosphorylation by IKK, IκBα and p105 are degradated in the proteasome, resulting in the nuclear translocation of canonical NF-κB family members, which bind to specific DNA elements, in the form of various dimeric complexes, including RELA-p50, c-REL-p50, and p50-p50. Atypical, IKK-independent pathways of NF-κB induction also provide mechanisms to integrate parallel signaling pathways to increase NF-κB activity, such as hypoxia, UV and genotoxic stress.

 

The non-canonical NF-κB pathway is induced by certain TNF superfamily members, such as CD40L, BAFF and lymphotoxin-β (LT-β), which stimulates the recruitment of TRAF2, TRAF3, cIAP1/2 to the receptor complex. Activated cIAP mediates K48 ubiquitylation and proteasomal degradation of TRAF3, resulting in stabilization and accumulation of the NFκB-inducing kinase (NIK). NIK phosphorylates and activates IKKα, which in turn phosphorylates p100, triggering p100 processing, and leading to the generation of p52 and the nuclear translocation of p52 and RELB[2][3].

 

Reference:

[1]. Oeckinghaus A, et al. The NF-kappaB family of transcription factors and its regulation.Cold Spring Harb Perspect Biol. 2009 Oct;1(4):a000034. 
[2]. Taniguchi K, et al. NF-κB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 2018 May;18(5):309-324.
[3]. Perkins ND,et al. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol. 2007 Jan;8(1):49-62.

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.